foxo4 dri patent FOXO4-DRI Research Peptide – 15mg Buy FOXO4-DRI 10mg | FOXO4
Buy FOXO4 DRI 10mg FOXO4 Research Peptide for Cellular Signaling Studies FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24



